Concepedia

Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma

Hua-Xiang Xu, Liang Liu, Jin-Feng Xiang, Wen-Quan Wang, Zi-Hao Qi, Chun-Tao Wu, Chen Liu, Jiang Long, Jin Xu, Quan-Xing Ni,

Surgery · 2016 · 61 citations · 19 references

DOI

Concepts

References

19

Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients With Resectable Pancreatic Adenocarcinoma

Cristina R. Ferrone, Dianne M. Finkelstein, Sarah P. Thayer et al. · Journal of Clinical Oncology · 2006 · 549 citations · Full text

, , +17

The prognostic and predictive value of serum CA19.9 in pancreatic cancer

Jeremy L. Humphris, David K. Chang, Amber L. Johns et al. · Annals of Oncology · 2012 · 304 citations · Full text

, , +17

CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy

Werner Hartwig, Oliver Strobel, Ulf Hinz et al. · Annals of Surgical Oncology · 2012 · 297 citations

, , +14

Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection

Darragh P. O’Brien, Neomal S. Sandanayake, Claire Jenkinson et al. · Clinical Cancer Research · 2014 · 198 citations · Full text

, , +14

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer

Guopei Luo, Chen Liu, Meng Guo et al. · Annals of Surgery · 2016 · 196 citations

, , +14